Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04553861
Other study ID # SamsungWatch
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2020
Est. completion date March 1, 2021

Study information

Verified date April 2021
Source Wonju Severance Christian Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This study aims to investigate the accuracy and precision of the Samsung Smartwatch with conventional ambulatory blood pressure monitoring in healthy volunteers.


Description:

Blood pressure (BP) monitoring outside of the medical care environment is an increasingly important part of clinical hypertension assessment and management. Ambulatory BP monitoring (ABPM) uses automatic detection and recording devices for repeated determinations during an extended period, typically 24 hours. This technique has been shown to substantially enhance the clinician's understanding of BP behavior in patients and aid in diagnosis and therapeutic decision making. The ABPM is superior to office BP in predicting target organ, hypertensive cerebrovascular disease, retinopathy, renal abnormalities, and alterations in vascular compliance.1-4) Most of these studies have also demonstrated that a loss of nocturnal decline in BP (so-called non-dipper) conveys excessive risk for stroke and myocardial infarction. Although conventional ABMP is usually well tolerated by patients, a few problems do exist. A minority of patients do not sleep well with the recorders and tend to have somewhat higher BP values. Cuffs can also rotate, and different arm positions can change BP significantly. Rarely, patients may develop erythema, ecchymoses, petechiae, or superficial phlebitis in the area distal to cuff placement. Recently, smartwatches that measure BP without a cuff have become available. Since these measurements are relatively more user-friendly than conventional cuff-based measurements, they may aid in more frequent BP monitoring. Currently, only one study compared a non-commercial armband wearable pulse transit time (PTT) system for 24-hour cuff-less BP measurement with ABPM.5) We will investigate the accuracy and precision of Samsung Smartwatch with ABPM in young, healthy volunteers.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date March 1, 2021
Est. primary completion date December 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion criteria - Ambulatory healthy subjects - Subjects aged 20 years or more - Subjects willing to participate in this study voluntarily Exclusion criteria - Subjects inability to provide informed consent - Subjects with any medical history - Subjects with irregular heart rhythm (e.g. atrial fibrillation, atrial flutter, or bigeminy) - Subjects unable to wear a watch due to wrist circumference - Subjects with BP difference 10mmHg or more between left and right arm

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ambulatory blood pressure monitoring
Every 30 minutes from 7 AM to 10 PM and every 1 hour from 10 PM to 7 AM
Galaxy Watch Active2
Every 1 hour by subject (on-demand) from 7 AM to 10 PM and every 5 minutes (automatic) from 10 PM to 7 AM

Locations

Country Name City State
Korea, Republic of Wonju Severance Christian Hospital Wonju Gangwon-do

Sponsors (2)

Lead Sponsor Collaborator
Wonju Severance Christian Hospital Samsung Electronics

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean nighttime blood pressure Correlation of mean nighttime BP between the ABPM and the BP using the smartwatch Baseline
Secondary Every time point blood pressure BP differences between the ABPM and the BP using the smartwatch at every time point of measurement Baseline
Secondary Mean 24-hour blood pressure Correlation of mean 24-h BP between the ABPM and the BP using the smartwatch Baseline
Secondary Mean daytime blood pressure Correlation of mean daytime BP between the ABPM and the BP using the smartwatch Baseline
Secondary Nighttime dipping Correlation of nighttime dipping between the ABPM and the BP using the smartwatch Baseline
Secondary Morning blood pressure Correlation of morning BP between the ABPM and the BP using the smartwatch Baseline
See also
  Status Clinical Trial Phase
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT05997303 - Continuous Norepinephrine Administration and Blood Pressure Stability During Anesthetic Induction N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT03918486 - Caretaker vs. Routine Blood Pressure Sphygmomanometer
Completed NCT03410342 - The Effects of Types of Fruits and Vegetables on Vascular Function N/A
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT04087070 - Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia
Completed NCT03294928 - Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers N/A
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03997461 - Comparison of Arterial Tonometry Sensor With Standard Oscillometric Blood Pressure Monitoring Device N/A
Completed NCT03290716 - Diet, ExerCIse and carDiovascular hEalth (DECIDE) - Salt Reduction Strategies for the Elderly in Nursing Homes in China N/A
Recruiting NCT06460233 - Blood Pressure Changes After Bariatric Surgery
Recruiting NCT05196048 - Blood Pressure Sensor of Watch-type Device With ECG Technology
Terminated NCT03325933 - Resistance Training and Cardiometabolic Health N/A
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Completed NCT02924454 - Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol. Phase 4
Completed NCT02451059 - Reducing Socioeconomic Disparities in Health at Pediatric Visits N/A
Active, not recruiting NCT02670967 - Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials N/A
Completed NCT02239744 - Intervention Study on the Health Impact of Air Filters in Chinese Adults N/A
Completed NCT02271633 - Nitrate Supplementation; Source Phase 4